Prof Nancy Rigotti
Professor of Medicine, Harvard Medical School
Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston
Nancy Rigotti, MD, is an internationally known expert in tobacco use, tobacco cessation, and tobacco control public policy. Trained as a general internist, she is Associate Chief of the Division of General Internal Medicine at Massachusetts General Hospital, a Professor of Medicine at Harvard Medical School, and Past President of both the Society for Research in Nicotine and Tobacco and the Society of General Internal Medicine. Dr. Rigotti founded and directs the Tobacco Research and Treatment Center at Massachusetts General Hospital. It combines a clinical service (MGH Tobacco Treatment Smoking Service) with a multidisciplinary research group whose mission is to develop innovative and effective smoking cessation treatment and tobacco control policy approaches.
Her research includes evaluations of tobacco control public policies and clinical trials of behavioral and pharmacologic smoking cessation treatments, with a focus on identifying system-level interventions suitable for various inpatient and outpatient health care settings in the U.S. and globally. She co-led the American College of Cardiology’s 2018 Consensus Decision Pathway on Tobacco Cessation Treatment. Dr. Rigotti was a member of the committee that produced the 2018 U.S. National Academies of Science, Engineering, and Medicine’s Report on the Public Health Consequences of Electronic Cigarettes. Her current work addressing the role of e-cigarettes for tobacco smoking cessation and harm reduction. Dr. Rigotti has authored over 300 publications.
- In our drive to protect kids Have we utilised e-cigarettes to focus on smokers and cessation?
Friday 4th December 4:00 pm
- Panel discussion and live Q&A: Tobacco control and THR – friend or foe?
Friday 4th December 4:30 pm